Most lately, it has been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in comparable locations as classical opioid receptors, it binds to a wide array of endogenous opioids. As opposed to most opioid receptors, this receptor functions like a scavenger https://derrickf233hyc2.blogdeazar.com/profile